Literature DB >> 12612065

Interleukin-3 stimulation of mcl-1 gene transcription involves activation of the PU.1 transcription factor through a p38 mitogen-activated protein kinase-dependent pathway.

Ju-Ming Wang1, Ming-Zong Lai, Hsin-Fang Yang-Yen.   

Abstract

We have previously demonstrated that the antiapoptotic gene mcl-1 is activated by interleukin-3 (IL-3) in Ba/F3 pro-B cells through two promoter elements designated the CRE-2 and SIE motifs. While the CRE-2-binding complex contains the CREB protein and is activated by IL-3 through the phosphatidylinositol 3-kinase/Akt-dependent pathway, the identity and cytokine activation pathway of the SIE-binding complex remains unclear. In this report, we demonstrated that PU.1 is one component of the SIE-binding complex. A chromatin immunoprecipitation assay further confirmed that PU.1 binds to the mcl-1 promoter region containing the SIE motif in vivo. While IL-3 stimulation does not significantly alter the SIE-binding activity of PU.1, it markedly increases PU.1's transactivation activity. The latter effect coincides with the increased phosphorylation of PU.1 following IL-3 activation of a p38 mitogen-activated protein kinase (p38(MAPK))-dependent pathway. A serine-to-alanine substitution at position 142 significantly weakens PU.1's ability to be phosphorylated by the p38(MAPK) immunocomplex. Furthermore, this S142A mutant is impaired in the ability to be further stimulated by IL-3 to transactivate the mcl-1 reporter through the SIE motif. Taken together, our results demonstrate that IL-3 stimulation of mcl-1 gene transcription through the SIE motif involves phosphorylation of PU.1 at serine 142 by a p38(MAPK)-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612065      PMCID: PMC149468          DOI: 10.1128/MCB.23.6.1896-1909.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain.

Authors:  J Bae; C P Leo; S Y Hsu; A J Hsueh
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  Mcl-1 deficiency results in peri-implantation embryonic lethality.

Authors:  J L Rinkenberger; S Horning; B Klocke; K Roth; S J Korsmeyer
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

3.  NF-IL6 (C/EBPbeta ) vigorously activates il1b gene expression via a Spi-1 (PU.1) protein-protein tether.

Authors:  Z Yang; N Wara-Aswapati; C Chen; J Tsukada; P E Auron
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

4.  Activation of transcription by PU.1 requires both acidic and glutamine domains.

Authors:  M J Klemsz; R A Maki
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

5.  Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways.

Authors:  H M Huang; C J Huang; J J Yen
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

6.  Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death.

Authors:  C D Bingle; R W Craig; B M Swales; V Singleton; P Zhou; M K Whyte
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

7.  Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway.

Authors:  C M Leu; C Chang; C Hu
Journal:  Oncogene       Date:  2000-03-23       Impact factor: 9.867

8.  Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.

Authors:  A M Stütz; M Woisetschläger
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

9.  The hematopoietic transcription factor PU.1 is downregulated in human multiple myeloma cell lines.

Authors:  M Pettersson; C Sundström; K Nilsson; L G Larsson
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

10.  Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B.

Authors:  H M Chen; P Zhang; M T Voso; S Hohaus; D A Gonzalez; C K Glass; D E Zhang; D G Tenen
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113

View more
  22 in total

Review 1.  Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Mol Med       Date:  2011-01-31       Impact factor: 5.600

2.  MAPK-mediated phosphorylation of GATA-1 promotes Bcl-XL expression and cell survival.

Authors:  Yung-Luen Yu; Yun-Jung Chiang; Yu-Chun Chen; Michael Papetti; Chiun-Gung Juo; Arthur I Skoultchi; Jeffrey J Y Yen
Journal:  J Biol Chem       Date:  2005-06-20       Impact factor: 5.157

3.  CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells.

Authors:  Yen-Chun Pan; Chien-Feng Li; Chiung-Yuan Ko; Min-Hsiung Pan; Pei-Jung Chen; Joseph T Tseng; Wen-Chun Wu; Wen-Chang Chang; A-Mei Huang; Esta Sterneck; Ju-Ming Wang
Journal:  Clin Cancer Res       Date:  2010-10-22       Impact factor: 12.531

4.  Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP.

Authors:  Hsuan Liu; Hsien-Wei Peng; Yi-Sheng Cheng; Hanna S Yuan; Hsin-Fang Yang-Yen
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 5.  T cell lineage commitment: identity and renunciation.

Authors:  Ellen V Rothenberg
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

6.  Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody.

Authors:  Kuen-Feng Chen; Hui-Ling Chen; Chung-Wai Shiau; Chun-Yu Liu; Pei-Yi Chu; Wei-Tien Tai; Kimihisa Ichikawa; Pei-Jer Chen; Ann-Lii Cheng
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

7.  Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.

Authors:  Martin Schwickart; Xiaodong Huang; Jennie R Lill; Jinfeng Liu; Ronald Ferrando; Dorothy M French; Heather Maecker; Karen O'Rourke; Fernando Bazan; Jeffrey Eastham-Anderson; Peng Yue; David Dornan; David C S Huang; Vishva M Dixit
Journal:  Nature       Date:  2009-12-20       Impact factor: 49.962

8.  Lipopolysaccharide-dependent interaction between PU.1 and c-Jun determines production of lipocalin-type prostaglandin D synthase and prostaglandin D2 in macrophages.

Authors:  Myungsoo Joo; Minjae Kwon; Yong-Jig Cho; Ningning Hu; Tetyana V Pedchenko; Ruxana T Sadikot; Timothy S Blackwell; John W Christman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-30       Impact factor: 5.464

9.  PTBP1 modulation of MCL1 expression regulates cellular apoptosis induced by antitubulin chemotherapeutics.

Authors:  J Cui; W J Placzek
Journal:  Cell Death Differ       Date:  2016-07-01       Impact factor: 15.828

10.  Notch signaling regulates expression of Mcl-1 and apoptosis in PPD-treated macrophages.

Authors:  Tanapat Palaga; Siriluk Ratanabunyong; Thitiporn Pattarakankul; Naunpun Sangphech; Wipawee Wongchana; Yukihiro Hadae; Patipark Kueanjinda
Journal:  Cell Mol Immunol       Date:  2013-07-22       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.